Fig. 5.
Complement-mediated killing of Ramos cells with serum from a mouse vaccinated with huCD20-avidin conjugate.
Serum plus complement was serially diluted as shown along the X-axis. Rituximab with complement (C′) was used as a positive control at 33 ng/mL, and rituximab or C′ alone was used as a negative control.